Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 3 4Phase 2 3Phase 1 3Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Carcinoma 3Prostatic Neoplasms 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Gallbladder Neoplasms 1Extensive Stage Small Cell Lung Carcinoma 1Epstein-Barr Virus Infections 1Carcinoma, Squamous Cell 1Advanced Glioblastoma 1

Interventions

Cisplatin 6Carboplatin 3spartalizumab 2Paclitaxel 2Drug Therapy 2Bevacizumab 2pembrolizumab 1netupitant, palosentron drug combination 1lenvatinib 1cyclopropapyrroloindole 1camrelizumab 1Vaccines, Synthetic 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Metronidazole 1Injections 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Docetaxel 1Dexamethasone 1Control Groups 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Uterine Cervical Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT01554397 2024-11-29

Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer

University of California, San Diego

Phase 2/3 Completed
101 enrolled 13 charts
Gynecologic

Carcinoma, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡